- £574.56m
- £520.37m
- £1.66bn
- 97
- 84
- 78
- 99
R2019 November 30th | 2020 November 30th | 2021 November 30th | 2022 November 30th | 2023 November 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,325 | 1,203 | 1,331 | 1,639 | 1,663 |
Cost of Revenue | |||||
Gross Profit | 338 | 309 | 356 | 431 | 419 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 1,267 | 1,171 | 1,270 | 1,562 | 1,587 |
Operating Profit | 57.8 | 31.8 | 61 | 77.6 | 76.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 56.8 | 30.6 | 60.2 | 77 | 77.9 |
Provision for Income Taxes | |||||
Net Income After Taxes | 41.3 | 18.8 | 42.3 | 54.2 | 56.1 |
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 41.3 | 17 | 42 | 54.2 | 56.1 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 41.3 | 17 | 42 | 54.2 | 56.1 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.347 | 0.17 | 0.331 | 0.426 | 0.45 |
Dividends per Share |